{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:38:31Z","timestamp":1791923911242,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04193-z","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T13:47:37Z","timestamp":1739627257000},"page":"863-872","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of the clinical significance of lymphocyte-based inflammatory indices between the two major subtypes of primary aldosteronism"],"prefix":"10.1007","volume":"88","author":[{"given":"Daisuke","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"issue":"5","key":"4193_CR1","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889\u20131916 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6018","key":"4193_CR2","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","volume":"331","author":"M Choi","year":"2011","unstructured":"M. Choi, U.I. Scholl, P. Yue et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331(6018), 768\u2013772 (2011)","journal-title":"Science"},{"issue":"5","key":"4193_CR3","first-page":"1633","volume":"84","author":"Y Takeda","year":"1999","unstructured":"Y. Takeda, K. Furukawa, S. Inaba, I. Miyamori, H. Mabuchi, Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism. J. Clin. Endocrinol. Metab. 84(5), 1633\u20131637 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4193_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ajh\/hpaa137","volume":"34","author":"NS Ferreira","year":"2021","unstructured":"N.S. Ferreira, R.C. Tostes, P. Paradis, E.L. Schiffrin, Aldosterone, inflammation, immune system, and hypertension. Am. J. Hypertens. 34(1), 15\u201327 (2021)","journal-title":"Am. J. Hypertens."},{"issue":"2","key":"4193_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12020-017-1348-8","volume":"57","author":"A Grotevendt","year":"2017","unstructured":"A. Grotevendt, H. Wallaschofski, M. Reincke et al. Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn\u2019s Registry. Endocrine 57(2), 298\u2013307 (2017)","journal-title":"Endocrine"},{"issue":"12","key":"4193_CR6","doi-asserted-by":"publisher","first-page":"bvaa153","DOI":"10.1210\/jendso\/bvaa153","volume":"4","author":"R Libianto","year":"2020","unstructured":"R. Libianto, J. Hu, M.R. Chee et al. A multicenter study of neutrophil-to-lymphocyte ratio in primary aldosteronism. J. Endocr. Soc. 4(12), bvaa153 (2020)","journal-title":"J. Endocr. Soc."},{"key":"4193_CR7","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.2147\/JIR.S409146","volume":"16","author":"KR Rao","year":"2023","unstructured":"K.R. Rao, R.Y. Bao, H. Ming, J.W. Liu, Y.F. Dong, The correlation between aldosterone and leukocyte-related inflammation: a comparison between patients with primary aldosteronism and essential hypertension. J. Inflamm. Res. 16, 2401\u20132413 (2023)","journal-title":"J. Inflamm. Res."},{"issue":"5","key":"4193_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1177\/1076029615569568","volume":"22","author":"S Balta","year":"2016","unstructured":"S. Balta, T. Celik, D.P. Mikhailidis et al. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin. Appl. Thromb. Hemost. 22(5), 405\u2013411 (2016)","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"1","key":"4193_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20385-3","volume":"12","author":"WW Ng","year":"2022","unstructured":"W.W. Ng, S.M. Lam, W.W. Yan, H.P. Shum, NLR, MLR, PLR and RDW to predict outcome and differentiate between viral and bacterial pneumonia in the intensive care unit. Sci. Rep. 12(1), 15974 (2022)","journal-title":"Sci. Rep."},{"issue":"4","key":"4193_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3343\/alm.2019.39.4.345","volume":"39","author":"AY Gasparyan","year":"2019","unstructured":"A.Y. Gasparyan, L. Ayvazyan, U. Mukanova, M. Yessirkepov, G.D. Kitas, The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann. Lab. Med. 39(4), 345\u2013357 (2019)","journal-title":"Ann. Lab. Med."},{"issue":"6","key":"4193_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"S. Matsuo, E. Imai, M. Horio et al. Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kidney. Dis. 53(6), 982\u2013992 (2009)","journal-title":"Am. J. Kidney. Dis."},{"issue":"9","key":"4193_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"T.A. Williams, J.W.M. Lenders, P. Mulatero et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet. Diabetes. Endocrinol. 5(9), 689\u2013699 (2017)","journal-title":"Lancet. Diabetes. Endocrinol."},{"issue":"9","key":"4193_CR13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"T. Nishikawa, M. Omura, F. Satoh et al. Guidelines for the diagnosis and treatment of primary aldosteronism\u2013the Japan Endocrine Society 2009. Endocr. J. 58(9), 711\u2013721 (2011)","journal-title":"Endocr. J."},{"issue":"3","key":"4193_CR14","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1210\/jcem.86.3.7287","volume":"86","author":"GP Rossi","year":"2001","unstructured":"G.P. Rossi, A. Sacchetto, M. Chiesura-Corona et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J. Clin. Endocrinol. Metab. 86(3), 1083\u20131090 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4193_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","volume":"39","author":"MC Corretti","year":"2002","unstructured":"M.C. Corretti, T.J. Anderson, E.J. Benjamin et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 39(2), 257\u2013265 (2002)","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"4193_CR16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1210\/jc.2015-3284","volume":"101","author":"T Kitamoto","year":"2016","unstructured":"T. Kitamoto, S. Suematsu, Y. Yamazaki et al. Clinical and steroidogenic characteristics of aldosterone-producing adenomas with ATPase or CACNA1D gene mutations. J. Clin. Endocrinol. Metab. 101(2), 494\u2013503 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"4193_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","volume":"18","author":"AF Turcu","year":"2022","unstructured":"A.F. Turcu, J. Yang, A. Vaidya, Primary aldosteronism - a multidimensional syndrome. Nat. Rev. Endocrinol. 18(11), 665\u2013682 (2022)","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"4193_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrneph.2013.110","volume":"9","author":"NJ Brown","year":"2013","unstructured":"N.J. Brown, Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat. Rev. Nephrol. 9(8), 459\u2013469 (2013)","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"4193_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","volume":"51","author":"NJ Brown","year":"2008","unstructured":"N.J. Brown, Aldosterone and vascular inflammation. Hypertension 51(2), 161\u2013167 (2008)","journal-title":"Hypertension"},{"issue":"2","key":"4193_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/(SICI)1096-8652(199910)62:2<65::AID-AJH1>3.0.CO;2-G","volume":"62","author":"S Grafte-Faure","year":"1999","unstructured":"S. Grafte-Faure, C. Leveque, M. Vasse, C. Soria, V. Norris, J.P. Vannier, Effects of glucocorticoids and mineralocorticoids on proliferation and maturation of human peripheral blood stem cells. Am. J. Hematol. 62(2), 65\u201373 (1999)","journal-title":"Am. J. Hematol."},{"key":"4193_CR21","doi-asserted-by":"publisher","first-page":"1415443","DOI":"10.3389\/fonc.2024.1415443","volume":"14","author":"L Ma","year":"2024","unstructured":"L. Ma, F. Yang, W. Guo, S. Tang, Y. Ling, Prognostic role of platelet-to-lymphocyte ratio in patients with rectal cancer undergoing resection: a systematic review and meta-analysis. Front. Oncol. 14, 1415443 (2024)","journal-title":"Front. Oncol."},{"issue":"7","key":"4193_CR22","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.3390\/ijms23073636","volume":"23","author":"A Buonacera","year":"2022","unstructured":"A. Buonacera, B. Stancanelli, M. Colaci, L. Malatino, Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int. J. Mol. Sci. 23(7), 3636 (2022)","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"4193_CR23","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1210\/jc.2018-00866","volume":"103","author":"Y Ohno","year":"2018","unstructured":"Y. Ohno, M. Sone, N. Inagaki et al. Obesity as a key factor underlying idiopathic hyperaldosteronism. J. Clin. Endocrinol. Metab. 103(12), 4456\u20134464 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4193_CR24","doi-asserted-by":"publisher","first-page":"678159","DOI":"10.1155\/2013\/678159","volume":"2013","author":"H Rodr\u00edguez-Hern\u00e1ndez","year":"2013","unstructured":"H. Rodr\u00edguez-Hern\u00e1ndez, L.E. Simental-Mend\u00eda, G. Rodr\u00edguez-Ram\u00edrez, M.A. Reyes-Romero, Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int. J. Endocrinol. 2013, 678159 (2013)","journal-title":"Int. J. Endocrinol."},{"issue":"1","key":"4193_CR25","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.dsx.2018.12.016","volume":"13","author":"A Abdel-Moneim","year":"2019","unstructured":"A. Abdel-Moneim, B. Mahmoud, E.A. Sultan, R. Mahmoud, Relationship of leukocytes, platelet indices and adipocytokines in metabolic syndrome patients. Diabetes. Metab. Syndr. 13(1), 874\u2013880 (2019)","journal-title":"Diabetes. Metab. Syndr."},{"issue":"8","key":"4193_CR26","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jdiacomp.2016.08.006","volume":"30","author":"J Surendar","year":"2016","unstructured":"J. Surendar, K. Indulekha, V. Mohan, R. Pradeepa, Association of neutrophil-lymphocyte ratio with metabolic syndrome and its components in Asian Indians (CURES-143). J. Diabetes. Complications. 30(8), 1525\u20131529 (2016)","journal-title":"J. Diabetes. Complications."},{"issue":"43","key":"4193_CR27","doi-asserted-by":"publisher","first-page":"e17537","DOI":"10.1097\/MD.0000000000017537","volume":"98","author":"CC Liu","year":"2019","unstructured":"C.C. Liu, H.J. Ko, W.S. Liu et al. Neutrophil-to-lymphocyte ratio as a predictive marker of metabolic syndrome. Medicine (Baltimore) 98(43), e17537 (2019)","journal-title":"Medicine (Baltimore)"},{"key":"4193_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13098-020-00562-y","volume":"12","author":"JR Wang","year":"2020","unstructured":"J.R. Wang, Z. Chen, K. Yang et al. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history. Diabetol. Metab. Syndr. 12, 55 (2020)","journal-title":"Diabetol. Metab. Syndr."},{"issue":"5","key":"4193_CR29","doi-asserted-by":"publisher","first-page":"e13085","DOI":"10.1111\/eci.13085","volume":"49","author":"JA Su\u00e1rez-Cuenca","year":"2019","unstructured":"J.A. Su\u00e1rez-Cuenca, A.S. Ru\u00edz-Hern\u00e1ndez, A.A. Mendoza-Casta\u00f1eda, G.A. Dom\u00ednguez-P\u00e9rez, A. Hern\u00e1ndez-Patricio, E. Vera-G\u00f3mez et al. Neutrophil-to-lymphocyte ratio and its relation with pro-inflammatory mediators, visceral adiposity and carotid intima-media thickness in population with obesity. Eur J Clin Invest 49(5), e13085 (2019)","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"4193_CR30","doi-asserted-by":"publisher","first-page":"101365","DOI":"10.1016\/j.jocd.2023.03.004","volume":"26","author":"AAB Arag\u00e3o","year":"2023","unstructured":"A.A.B. Arag\u00e3o, E. Bouskela, D.A. Bottino, A cross-sectional study of adiposity by DXA and the relationship with endothelial function and low-grade inflammation. J Clin Densitom 26(2), 101365 (2023)","journal-title":"J Clin Densitom"},{"key":"4193_CR31","doi-asserted-by":"publisher","first-page":"647184","DOI":"10.3389\/fendo.2021.647184","volume":"12","author":"KM Chen","year":"2021","unstructured":"K.M. Chen, B.C. Lee, P.T. Chen, K.L. Liu, K.H. Lin, C.C. Chang et al. Evaluation of abdominal computed tomography scans for differentiating the discrepancies in abdominal adipose tissue between two major subtypes of primary aldosteronism. Front Endocrinol (Lausanne) 12, 647184 (2021)","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"4193_CR32","doi-asserted-by":"publisher","first-page":"e4066","DOI":"10.1210\/clinem\/dgaa595","volume":"105","author":"K Nanba","year":"2020","unstructured":"K. Nanba, Y. Yamazaki, N. Bick et al. Prevalence of somatic mutations in aldosterone-producing adenomas in Japanese Patients. J. Clin. Endocrinol. Metab. 105(11), e4066\u20134073 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"4193_CR33","doi-asserted-by":"publisher","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","volume":"100","author":"L Lenzini","year":"2015","unstructured":"L. Lenzini, G. Rossitto, G. Maiolino, C. Letizia, J.W. Funder, G.P. Rossi, A meta-analysis of somatic KCNJ5 K(+) channel mutations In 1636 patients with an aldosterone-producing adenoma. J. Clin. Endocrinol. Metab. 100(8), E1089\u20131095 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4193_CR34","doi-asserted-by":"publisher","first-page":"1061704","DOI":"10.3389\/fendo.2023.1061704","volume":"14","author":"YY Chang","year":"2023","unstructured":"Y.Y. Chang, B.C. Lee, Z.W. Chen et al. Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism. Front. Endocrinol. (Lausanne) 14, 1061704 (2023)","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"4193_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10741-005-2346-0","volume":"10","author":"HV Joffe","year":"2005","unstructured":"H.V. Joffe, G.K. Adler, Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation. Heart Failure Rev. 10(1), 31\u201337 (2005)","journal-title":"Heart Failure Rev."},{"issue":"9","key":"4193_CR36","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","volume":"79","author":"F Buffolo","year":"2022","unstructured":"F. Buffolo, M. Tetti, P. Mulatero, S. Monticone, Aldosterone as a mediator of cardiovascular damage. Hypertension 79(9), 1899\u20131911 (2022)","journal-title":"Hypertension"},{"issue":"1","key":"4193_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12872-017-0507-4","volume":"17","author":"H Ji","year":"2017","unstructured":"H. Ji, Y. Li, Z. Fan et al. Monocyte\/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessment. BMC Cardiovasc. Disord. 17(1), 90 (2017)","journal-title":"BMC Cardiovasc. Disord."},{"key":"4193_CR38","doi-asserted-by":"publisher","first-page":"406960","DOI":"10.1155\/2014\/406960","volume":"2014","author":"QN Dinh","year":"2014","unstructured":"Q.N. Dinh, G.R. Drummond, C.G. Sobey, S. Chrissobolis, Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed. Res. Int. 2014, 406960 (2014)","journal-title":"Biomed. Res. Int."},{"issue":"11","key":"4193_CR39","doi-asserted-by":"publisher","first-page":"dgaa566","DOI":"10.1210\/clinem\/dgaa566","volume":"105","author":"CK Chan","year":"2020","unstructured":"C.K. Chan, W.S. Yang, Y.H. Lin et al. Arterial stiffness is associated with clinical outcome and cardiorenal injury in lateralized primary aldosteronism. J. Clin. Endocrinol. Metab. 105(11), dgaa566 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4193_CR40","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1016\/j.jfma.2023.05.004","volume":"123","author":"YH Yang","year":"2024","unstructured":"Y.H. Yang, Y.L. Chang, B.C. Lee et al. Strategies for subtyping primary aldosteronism. J. Formos. Med. Assoc. 123, S114\u2013124 (2024). Suppl 2","journal-title":"J. Formos. Med. Assoc."},{"issue":"5","key":"4193_CR41","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1507\/endocrj.EJ22-0585","volume":"70","author":"H Kobayashi","year":"2023","unstructured":"H. Kobayashi, Y. Nakamura, M. Abe et al. Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism. Endocr. J. 70(5), 489\u2013500 (2023)","journal-title":"Endocr. J."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04193-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04193-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04193-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T16:03:32Z","timestamp":1749225812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04193-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["4193"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04193-z","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}